Nuzenio

Wedbush Upgrades Replimune

Wedbush Upgrades Replimune news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 19:32:14 GMTREPL Upgraded by Wedbush -- Price Target Raised to $19.00 - GuruFocus
Fri, 07 Aug 2026 15:53:51 GMTReplimune price target raised to $20 from $16 at BMO Capital - tipranks.com
Fri, 07 Aug 2026 11:58:00 GMTWedbush Upgrades Replimune (REPL) on FDA Approval, Price Target Raised to $19 - GuruFocus
Tue, 04 Aug 2026 12:08:07 GMTLeerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11 - marketscreener.com
Fri, 31 Jul 2026 07:00:00 GMTWedbush Upgrades Replimune Group to Outperform From Neutral, Raises Price Target to $12 From $9 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Wedbush Upgrades Replimune.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.